Buy your weekday smoothies and get your weekend ones for free. (7 for the price of 5!)
Generally Recognized As Safe (GRAS) Study Results
The study assessed the preclinical safety of a glycosides-based standardized fenugreek seed extract (SFSE-G) through acute, subchronic toxicity, and mutagenicity tests in Sprague-Dawley rats. Results showed no mortality or significant adverse effects at doses up to 2000 mg/kg, indicating a median lethal dose greater than this value. The no-observed adverse effect levels were established at 1000 mg/kg for male and 500 mg/kg for female rats, with no mutagenic potential identified.
Highlights -π
- Safety Profile: SFSE-G demonstrated safety in acute and subchronic toxicity studies. β
- No Mortality: No deaths occurred in rats even at high doses. π«
- LD50 Established: Median lethal dose exceeded 2000 mg/kg. βοΈ
- NOAEL Identified: No-observed adverse effect levels at 1000 mg/kg (male) and 500 mg/kg (female). π
- Mutagenicity Test: No mutagenic effects detected in vitro. π§¬
- Hematological Stability: Blood parameters remained within normal ranges. π
- Regulatory Compliance: Study followed OECD guidelines for toxicity testing. π
Key Insights -π‘
-
Significant Safety Findings: The high LD50 and established NOAEL indicate that SFSE-G is safe for consumption and may be suitable for further clinical testing, enhancing the credibility of herbal supplements in medical applications. πΏ
-
Absence of Toxicity Symptoms: The lack of clinical signs and mortality across all tested doses suggests that SFSE-G does not pose acute toxicity risks, supporting its use in traditional medicine. β οΈ
-
Comprehensive Toxicological Assessment: The studyβs adherence to OECD guidelines strengthens its findings, providing a robust framework for evaluating herbal medicines and ensuring consumer safety. π
-
Hematological Safety: The stable blood parameters observed indicate that SFSE-G does not negatively impact erythropoiesis or immune function, which is critical for long-term herbal supplement use. π©Έ
-
No Mutagenic Risk: The absence of mutagenic effects suggests that SFSE-G could be safely integrated into dietary supplements without concerns related to genetic damage, which is vital for consumer health. π‘οΈ
-
Potential for Broader Applications: Given its safety profile, SFSE-G may be explored for various therapeutic applications, particularly in enhancing male health and hormonal balance. π
-
Future Clinical Implications: The established safety parameters support the potential for clinical trials to evaluate the efficacy of SFSE-G in humans, paving the way for evidence-based herbal medicine. π₯
